Kyowa Kirin to acquire Orchard Therapeutics in deal worth $477m
The deal gives Kyowa access to a therapy for early-onset metachromatic leukodystrophy
Read More
Tag: Orchard Therapeutics
NICE ‘no’ for Orchard Therapeutics’ gene therapy Libmeldy
NICE concluded the cost-effectiveness estimates for Libmeldy are unlikely to be within the range that it would consider an effective use of NHS resources
Read More
Orchard raises $150m to advance gene therapies
UK-American biotech Orchard Therapeutics has raised $150 million to fuel development of its gene therapy pipeline.
Read More
